The deal adds hepatitis B and early-stage shingles vaccines as Sanofi faces pipeline pressure from tolebrutinib setback.

Sanofi (NASDAQ:SNY) is one of the Best Affordable Stocks to Buy According to Analysts. On December 24, Sanofi (NASDAQ:SNY) ...

Unless such surprises materialize, analysts like Phipps see the Dynavax story as largely written, with most of the remaining upside and downside bounded by Sanofi’s $15.50 per share offer. Inhibikase ...

The post Dynavax Shares Jump On Vaccine News appeared first on Self Employed.

Dow Jones Top Company Headlines at 9 AM ET: China Sanctions Boeing, Other U.S. Companies Over Taiwan Arms Sale | Rolex ... China Sanctions Boeing, Other U.S. Companies Over Taiwan Arms Sale Beijing ...

The Dow Jones Industrial Average ​rose ‌288.75 points, or 0.60%, to 48,731.16, ‍the S&P 500 gained 22.26 points, ⁠or 0.32%, to 6,932.05 and the Nasdaq Composite gained 51.46 points, or 0.22%, to ...

Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...

Dow Jones Top Company Headlines at 11 AM ET: Tesla Under Investigation by U.S. Regulator for Model 3 Door Release Defects | Nike ... Tesla Under Investigation by U.S. Regulator for Model 3 Door ...

Dynavax soared by 38.19 percent on Wednesday to close at $15.38 apiece as investors took heart from news that it was set to ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The S&P 500 index rose 22.26 ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

Dynavax Technologies shares jumped more than 38% Wednesday after Sanofi announced a $15.50-per-share acquisition offer, valuing the company at roughly $2.2 billion.